Thermo Fisher Scientific | TMO - Des Atouts





Des Atouts Changement Date
Abbott USD 110.43B 23.72B 2026-03
Agilent USD 13.07B 252M 2026-03
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Bio Techne USD 2.55B 27.9M 2026-03
Bio-Rad Laboratories USD 10.25B 462M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
Bruker USD 6.05B 77.8M 2026-06
Charles River Laboratories USD 7.53B 198.16M 2026-06
Danaher USD 92.37B 8.82B 2026-06
Dentsply International USD 5.2B 25M 2026-06
Edwards Lifesciences USD 13.87B 545.9M 2026-06
General Electric Aerospace USD 127.67B 773M 2026-06
Henry Schein USD 11.38B 77M 2026-06
Illumina USD 6.65B 91M 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Laboratory Of America USD 18.53B 554.8M 2026-06
Medtronic USD 91.48B 139M 2025-12
Mettler Toledo International USD 3.67B 2.03M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
Olympus JPY 1.53T 10.69B 2026-06
OraSure Technologies USD 360.55M 18.62M 2026-06
Quest Diagnostics USD 16.94B 266M 2026-06
Repligen USD 2.95B 19.41M 2026-06
Revvity USD 12.05B 49.24M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Veracyte USD 1.49B 49.97M 2026-06
Waters USD 24.75B 220M 2026-06
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06